参考文献/References:
[1]鲁之中,李军民,胡云芝,等.食管癌患者miR-182表达水平及其对预后的影响[J].中国现代医学杂志,2017,27(24):39-43.
[2]秦福双.MRI对食管癌T分期诊断及手术切除中的评估价值分析[J].中国CT和MRI杂志,2018,16(1):94-97.
[3]周凯,王伟,相加庆.新辅助化放疗联合手术治疗局部晚期食管癌30例[J].中国临床研究,2018,31(10):85-88.
[4]王绿化,傅小龙,陈明,等.放射性肺损伤的诊断及治疗[J].中华放射肿瘤学杂志,2015,24(1):4-9.
[5]郑苗丽,冯勤付.放射性肺损伤的研究进展[J].中华放射肿瘤学杂志,2018,27(7):692-695.
[6]Rabe KF,Hurd S,Anzueto A,et al.Global Initiative forChronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J].Am J Respir Crit Care Med,2007,176(6):532-555.
[7]闵茜,胡伟国,宋启斌.放射性肺损伤发生机制的研究进展[J].肿瘤学杂志,2016,22(2):88-92.
[8]林佳.胸部肿瘤放疗后致急性放射性肺损伤的相关因素分析[J].现代诊断与治疗,2017,28(17):3242-3244.
[9]Kimura T,Togami T,Takashima H,et al.Radiation pneumonitisin patients with lung and mediastinal tumours:a retrospective study of risk factors focused on pulmonary emphysema[J].Br J Radiol,2012(85):135-141.
[10]Takeda A,Kunieda E,OhasPhi T,et al.Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy[J].Chest,2012,141(4):858-866.
[11]张毅,任秦有,郑瑾,等.放射性肺损伤的研究进展[J].现代肿瘤医学,2015,28(5):712-715.
[12]常晓龙,王明臣,刘雪,等.盐酸氨溴索在放射性肺损伤中的保护作用及对血浆TGF-β1和TNF-α水平的影响[J].广州医药,2015,46(1):8-10.
[13]Takeda A,Ohashi T,Kunieda E,et al.Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereo tactic body radiotherapy(SBRT) in patients with lung tumors[J].Int J Radiat Oncol Biolhys,2010,77(3):685-690.
[14]Yamashita H,Kobayashi-Shibata S,Terahara A,et al.Prescreening based on the presence of CT-scan abnormalities and biomarkers(KL-6 and SP-D)may reduce severe radiation pneumonitis after stereotactic radiotherapy[J].Radiat Oncol,2010(5):32.
[15]杨志勇,陈传喜.非小细胞肺癌患者放射性肺损伤的临床特点分析[J].中国肿瘤临床与康复,2015,21(1):7-8.
[16]王志勇.三维适形放疗并发放射性肺炎的CT影像特点[J].中国医药指南,2017,15(19):159-160.
相似文献/References:
[1]汪 兵,杜 铭.食管癌微创手术与机器人手术的研究[J].医学信息,2018,31(06):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
WANG Bing,DU Ming.Study on Minimally Invasive Surgery and Robotic Surgery for Esophageal Carcinoma[J].Journal of Medical Information,2018,31(14):34.[doi:10.3969/j.issn.1006-1959.2018.06.012]
[2]许益芬.三维适型放疗与调强放疗在胸中段食管癌根治性放疗中的
剂量学比较[J].医学信息,2018,31(13):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
XU Yi-fen.Dosimetric Comparison of Three-dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Radical Radiotherapy of Middle Thoracic Esophageal Carcinoma[J].Journal of Medical Information,2018,31(14):73.[doi:10.3969/j.issn.1006-1959.2018.13.021]
[3]茹仙古丽·艾尔西丁,木拉提·哈米提,严传波,等.RF和C4.5决策树在食管癌图像分类中的研究[J].医学信息,2018,31(22):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
Roxangvl·Arxidin,Murat·Hamit,YAN Chuan-bo,et al.Research on RF and C4.5 Decision Tree in Image Classification of Esophageal Cancer[J].Journal of Medical Information,2018,31(14):51.[doi:10.3969/j.issn.1006-1959.2018.22.015]
[4]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(14):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
[5]杨玥欣,汪 志,杨 欣,等.食管癌放疗的剂量学和临床疗效研究[J].医学信息,2020,33(04):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
YANG Yue-xin,WANG Zhi,YANG Xin,et al.Dosimetry and Clinical Efficacy of Radiotherapy for Esophageal Cancer[J].Journal of Medical Information,2020,33(14):72.[doi:10.3969/j.issn.1006-1959.2020.04.022]
[6]刘安东,刘崇华,王园园.参麦注射液联合放射治疗对中晚期食管癌老年患者的疗效[J].医学信息,2020,33(16):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
LIU An-dong,LIU Chong-hua,WANG Yuan-yuan.The Effect of Shenmai Injection Combined with Radiotherapy on Elderly Patients with Advanced Esophageal Cancer[J].Journal of Medical Information,2020,33(14):152.[doi:10.3969/j.issn.1006-1959.2020.16.048]
[7]赵素素,谭洁琼,党 娟.食管癌术后恢复期补液量与术后恢复的关系[J].医学信息,2021,34(04):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
ZHAO Su-su,TAN Jie-qiong,DANG Juan.The Relationship Between the Amount of Fluid Supplementation in the Recovery Period and Postoperative Recovery of Esophageal Cancer[J].Journal of Medical Information,2021,34(14):88.[doi:10.3969/j.issn.1006-1959.2021.04.023]
[8]吴伯勋,刘 浩,刘洪利.香砂六君子汤在微创食管癌切除术后肠功能恢复中的应用效果[J].医学信息,2021,34(06):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]
WU Bo-xun,LIU Hao,LIU Hong-li.Application Effect of Xiangsha Liujunzi Decoction in Recovery of Bowel Function After Minimally Invasive Esophageal Cancer Resection[J].Journal of Medical Information,2021,34(14):169.[doi:10.3969/j.issn.1006-1959.2021.06.045]
[9]王成师,何中祥,蒋书凤,等.同步放化疗在食管癌术后纵隔淋巴结转移患者中的应用[J].医学信息,2021,34(21):156.[doi:10.3969/j.issn.1006-1959.2021.21.044]
WANG Cheng-shi,HE Zhong-xiang,JIANG Shu-feng,et al.Application of Concurrent Chemoradiotherapy in Patients with Mediastinal Lymph Node Metastasis After Esophagectomy[J].Journal of Medical Information,2021,34(14):156.[doi:10.3969/j.issn.1006-1959.2021.21.044]
[10]孙 甫,兰翠茹,熊卫平,等.铅门跟随技术对食管癌调强放疗计划质控的影响[J].医学信息,2022,35(04):133.[doi:10.3969/j.issn.1006-1959.2022.04.034]
SUN Fu,LAN Cui-ru,XIONG Wei-ping,et al.The Impact of Jaw Tracking Technique on Plan Quality Assurance of Intensity-modulatedRadiotherapy for esophageal cancer[J].Journal of Medical Information,2022,35(14):133.[doi:10.3969/j.issn.1006-1959.2022.04.034]